Pain Management Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065120
  • May 2021
  • Pharmaceuticals
  • 130 Pages
The Pain Management Drugs Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott Laboratories, Endo Health Solutions, AstraZeneca Plc., Eli Lilly & Company, GlaxoSmithKline Plc., Johnson & Johnson, Teva Pharmaceuticals, Mallinckrodt Plc., Novartis AG, Merck & Co. Inc., urdue Pharma LP, fizer Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Pain Management Drugs market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Pain Management Drugs market is expected to attain Pre COVID-19 levels by mid-2022.

Pain Management Drugs Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Pain Management Drugs market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Pain Management Drugs Market Competitive and Premeditated Analysis
In the Pain Management Drugs report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Pain Management Drugs research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Pain Management Drugs Market:
The Pain Management Drugs market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott Laboratories, Endo Health Solutions, AstraZeneca Plc., Eli Lilly & Company, GlaxoSmithKline Plc., Johnson & Johnson, Teva Pharmaceuticals, Mallinckrodt Plc., Novartis AG, Merck & Co. Inc., urdue Pharma LP, fizer Inc.

The Pain Management Drugs market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Pain Management Drugs Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Pain Management Drugs market:
by Therapeutics
Anticonvulsants
Antidepressants
Anesthetics
Non-steroidal Anti-inflammatory Drugs
NSAIDS
Opioids
Antimigraine Agents
Other Non-narcotic Analgesic
Indication
Neuropathic Pain
Fibromyalgia
Arthritic Pain
Chronic Back Pain
Migraine
Post-Operative Pain
Cancer Pain

Regional Analysis of the Pain Management Drugs market:
The Pain Management Drugs market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Pain Management Drugs report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Pain Management Drugs market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Pain Management Drugs market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Pain Management Drugs market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Pain Management Drugs market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Pain Management Drugs market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Pain Management Drugs market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Pain Management Drugs market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Pain Management Drugs market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott Laboratories
  • Endo Health Solutions
  • AstraZeneca Plc.
  • Eli Lilly & Company
  • GlaxoSmithKline Plc.
  • Johnson & Johnson
  • Teva Pharmaceuticals
  • Mallinckrodt Plc.
  • Novartis AG
  • Merck & Co. Inc.
  • urdue Pharma LP
  • fizer Inc.
  • Anticonvulsants
  • Antidepressants
  • Anesthetics
  • Non-steroidal Anti-inflammatory Drugs
  • NSAIDS
  • Neuropathic Pain
  • Fibromyalgia
  • Arthritic Pain
  • Chronic Back Pain
  • Migraine
  • Post-Operative Pain
  • Cancer Pain

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Pain Management Drugs Market Snapshot
          2.1.1. Global Pain Management Drugs Market By Therapeutics,2019
               2.1.1.1.Anticonvulsants
               2.1.1.2.Antidepressants
               2.1.1.3.Anesthetics
               2.1.1.4.Non-steroidal Anti-inflammatory Drugs
               2.1.1.5.NSAIDS
          2.1.2. Global Pain Management Drugs Market By Indication,2019
               2.1.2.1.Neuropathic Pain
               2.1.2.2.Fibromyalgia
               2.1.2.3.Arthritic Pain
               2.1.2.4.Chronic Back Pain
               2.1.2.5.Migraine
               2.1.2.6.Post-Operative Pain
               2.1.2.7.Cancer Pain
          2.1.3. Global Pain Management Drugs Market By End-use,2019
          2.1.4. Global Pain Management Drugs Market By Geography,2019

3. Global Pain Management Drugs Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Pain Management Drugs Market Size (US$), By Therapeutics, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Therapeutics, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Therapeutics, 2020
     4.2. Global Pain Management Drugs Market Size (US$), By Therapeutics, 2018 – 2028

5. Global Pain Management Drugs Market Size (US$), By Indication, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Indication, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Indication, 2020
     5.2. Global Pain Management Drugs Market Size (US$), By Indication, 2018 – 2028

6. Global Pain Management Drugs Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Pain Management Drugs Market Size (US$), By End-use, 2018 – 2028

7. Global Pain Management Drugs Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Pain Management Drugs Market Analysis, 2018 – 2028 
          7.2.1. North America Pain Management Drugs Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Pain Management Drugs Market Size (US$), By Therapeutics, 2018 – 2028
          7.2.3. North America Pain Management Drugs Market Size (US$), By Indication, 2018 – 2028
          7.2.4. North America Pain Management Drugs Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Pain Management Drugs Market Analysis, 2018 – 2028 
          7.3.1.  Europe Pain Management Drugs Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Pain Management Drugs Market Size (US$), By Therapeutics, 2018 – 2028
          7.3.3. Europe Pain Management Drugs Market Size (US$), By Indication, 2018 – 2028
          7.3.4. Europe Pain Management Drugs Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Pain Management Drugs Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Pain Management Drugs Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Pain Management Drugs Market Size (US$), By Therapeutics, 2018 – 2028
          7.4.3. Asia Pacific Pain Management Drugs Market Size (US$), By Indication, 2018 – 2028
          7.4.4. Asia Pacific Pain Management Drugs Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Pain Management Drugs Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Pain Management Drugs Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Pain Management Drugs Market Size (US$), By Therapeutics, 2018 – 2028
          7.5.3. Latin America Pain Management Drugs Market Size (US$), By Indication, 2018 – 2028
          7.5.4. Latin America Pain Management Drugs Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Pain Management Drugs Market Analysis, 2018 – 2028 
          7.6.1.  MEA Pain Management Drugs Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Pain Management Drugs Market Size (US$), By Therapeutics, 2018 – 2028
          7.6.3. MEA Pain Management Drugs Market Size (US$), By Indication, 2018 – 2028
          7.6.4. MEA Pain Management Drugs Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Pain Management Drugs Providers
        8.4.1 Abbott Laboratories
                8.4.1.1 Business Description
                8.4.1.2 Abbott Laboratories Geographic Operations
                8.4.1.3 Abbott Laboratories Financial Information
                8.4.1.4 Abbott Laboratories Product Positions/Portfolio
                8.4.1.5 Abbott Laboratories Key Developments
        8.4.2 Endo Health Solutions
                8.4.2.1 Business Description
                8.4.2.2 Endo Health Solutions Geographic Operations
                8.4.2.3 Endo Health Solutions Financial Information
                8.4.2.4 Endo Health Solutions Product Positions/Portfolio
                8.4.2.5 Endo Health Solutions Key Developments
        8.4.3 AstraZeneca Plc.
                8.4.3.1 Business Description
                8.4.3.2 AstraZeneca Plc. Geographic Operations
                8.4.3.3 AstraZeneca Plc. Financial Information
                8.4.3.4 AstraZeneca Plc. Product Positions/Portfolio
                8.4.3.5 AstraZeneca Plc. Key Developments
        8.4.4 Eli Lilly & Company
                8.4.4.1 Business Description
                8.4.4.2 Eli Lilly & Company Geographic Operations
                8.4.4.3 Eli Lilly & Company Financial Information
                8.4.4.4 Eli Lilly & Company Product Positions/Portfolio
                8.4.4.5 Eli Lilly & Company Key Developments
        8.4.5 GlaxoSmithKline Plc.
                8.4.5.1 Business Description
                8.4.5.2 GlaxoSmithKline Plc. Geographic Operations
                8.4.5.3 GlaxoSmithKline Plc. Financial Information
                8.4.5.4 GlaxoSmithKline Plc. Product Positions/Portfolio
                8.4.5.5 GlaxoSmithKline Plc. Key Developments
        8.4.6 Johnson & Johnson
                8.4.6.1 Business Description
                8.4.6.2 Johnson & Johnson Geographic Operations
                8.4.6.3 Johnson & Johnson Financial Information
                8.4.6.4 Johnson & Johnson Product Positions/Portfolio
                8.4.6.5 Johnson & Johnson Key Developments
        8.4.7 Teva Pharmaceuticals
                8.4.7.1 Business Description
                8.4.7.2 Teva Pharmaceuticals Geographic Operations
                8.4.7.3 Teva Pharmaceuticals Financial Information
                8.4.7.4 Teva Pharmaceuticals Product Positions/Portfolio
                8.4.7.5 Teva Pharmaceuticals Key Developments
        8.4.8 Mallinckrodt Plc.
                8.4.8.1 Business Description
                8.4.8.2 Mallinckrodt Plc. Geographic Operations
                8.4.8.3 Mallinckrodt Plc. Financial Information
                8.4.8.4 Mallinckrodt Plc. Product Positions/Portfolio
                8.4.8.5 Mallinckrodt Plc. Key Developments
        8.4.9 Novartis AG
                8.4.9.1 Business Description
                8.4.9.2 Novartis AG Geographic Operations
                8.4.9.3 Novartis AG Financial Information
                8.4.9.4 Novartis AG Product Positions/Portfolio
                8.4.9.5 Novartis AG Key Developments
        8.4.10 Merck & Co. Inc.
                8.4.10.1 Business Description
                8.4.10.2 Merck & Co. Inc. Geographic Operations
                8.4.10.3 Merck & Co. Inc. Financial Information
                8.4.10.4 Merck & Co. Inc. Product Positions/Portfolio
                8.4.10.5 Merck & Co. Inc. Key Developments
        8.4.11 urdue Pharma LP
                8.4.11.1 Business Description
                8.4.11.2 urdue Pharma LP Geographic Operations
                8.4.11.3 urdue Pharma LP Financial Information
                8.4.11.4 urdue Pharma LP Product Positions/Portfolio
                8.4.11.5 urdue Pharma LP Key Developments
        8.4.12 fizer Inc.
                8.4.12.1 Business Description
                8.4.12.2 fizer Inc. Geographic Operations
                8.4.12.3 fizer Inc. Financial Information
                8.4.12.4 fizer Inc. Product Positions/Portfolio
                8.4.12.5 fizer Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Pain Management Drugs Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Pain Management Drugs Market Revenue, By Therapeutics, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Pain Management Drugs Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Pain Management Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Pain Management Drugs Market Revenue, By Therapeutics, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Pain Management Drugs Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Pain Management Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Pain Management Drugs Market Revenue, By Therapeutics, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Pain Management Drugs Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Pain Management Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Pain Management Drugs Market Revenue, By Therapeutics, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Pain Management Drugs Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Pain Management Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Pain Management Drugs Market Revenue, By Therapeutics, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Pain Management Drugs Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Pain Management Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Pain Management Drugs: Market Segmentation 
FIG. 2 Global Pain Management Drugs Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Pain Management Drugs Market, By Therapeutics, 2019 (US$ Mn) 
FIG. 5 Global Pain Management Drugs Market, By Indication, 2019 (US$ Mn) 
FIG. 6 Global Pain Management Drugs Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Pain Management Drugs Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Pain Management Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Pain Management Drugs Providers, 2019
FIG. 11 Global Pain Management Drugs Market Revenue Contribution, By Therapeutics, 2019 & 2028 (Value %) 
FIG. 12 Global Pain Management Drugs Market Revenue Contribution, By Indication, 2019 & 2028 (Value %) 
FIG. 13 Global Pain Management Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Pain Management Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Pain Management Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Pain Management Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Pain Management Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Pain Management Drugs Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Pain Management Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Pain Management Drugs Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Pain Management Drugs Market Value, By Segment1, 2018 – 2028
TABLE  North America Pain Management Drugs Market Value, By Segment2, 2018 – 2028
TABLE  North America Pain Management Drugs Market Value, By Country, 2018 – 2028
TABLE  Europe Pain Management Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Europe Pain Management Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Europe Pain Management Drugs Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Pain Management Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Pain Management Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Pain Management Drugs Market Value, By Country, 2018 – 2028
TABLE  Latin America Pain Management Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Pain Management Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Pain Management Drugs Market Value, By Country, 2018 – 2028
TABLE  MEA Pain Management Drugs Market Value, By Segment1, 2018 – 2028
TABLE  MEA Pain Management Drugs Market Value, By Segment2, 2018 – 2028
TABLE  MEA Pain Management Drugs Market Value, By Country, 2018 – 2028
TABLE  Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Endo Health Solutions: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly & Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mallinckrodt Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co. Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  urdue Pharma LP: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  fizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Pain Management Drugs Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Pain Management Drugs Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Pain Management Drugs Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Pain Management Drugs Market, By Geography, 2019 (US$ Mn)
FIG.  Global Pain Management Drugs Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Pain Management Drugs Providers, 2016
FIG.  Global Pain Management Drugs Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Antidepressants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Anesthetics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Non-steroidal Anti-inflammatory Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global NSAIDS Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Pain Management Drugs Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Fibromyalgia Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Arthritic Pain Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Chronic Back Pain Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Migraine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Post-Operative Pain Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cancer Pain Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Pain Management Drugs Market Value, 2018 – 2028, (US$ Mn)